Merck & Co. Continues to Look at NK Cell Engager Therapies with Dragonfly Therapeutics Pact
By Michelle Liu
Pharma Deals Review: Vol 2018 Issue 11 (Table of Contents)
Published: 10 Nov-2018
DOI: 10.3833/pdr.v2018.i11.2370 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a deal worth at least US$695 M, Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS